Taylor Morrison Home (TMHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Jun, 2026Executive summary
Special meeting scheduled for July 22, 2026, to vote on a merger agreement where TMHC will merge with a Berkshire Hathaway subsidiary and become a wholly owned subsidiary, with stockholders receiving $72.50 per share in cash, representing a 24% premium over the pre-announcement price.
The board unanimously recommends voting in favor of the merger, the advisory compensation proposal, and the adjournment proposal.
The merger is expected to close in the second half of 2026, subject to regulatory approvals and other customary conditions.
Voting matters and shareholder proposals
Stockholders will vote on: (1) adoption of the merger agreement, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) a proposal to adjourn the meeting if more time is needed to solicit votes.
Approval of the merger requires a majority of outstanding shares; the advisory compensation and adjournment proposals require a majority of shares present or represented by proxy.
Dissenting stockholders may seek appraisal rights under Delaware law.
Board of directors and corporate governance
The board conducted a comprehensive review of strategic alternatives and determined the merger was in the best interests of stockholders.
The board considered financial analyses, fairness opinions, and the likelihood of consummation, and negotiated terms including the ability to consider superior proposals subject to a termination fee.
The board is composed of a majority of independent directors who unanimously approved the transaction.
Latest events from Taylor Morrison Home
- Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20259 Jul 2026 - Aims for 20,000 closings by 2028 with digital innovation, capital discipline, and high-teen ROE.TMHC
Investor Day 20258 Jul 2026 - Q3 net income up 54% to $251M, with strong revenue, margin gains, and robust guidance.TMHC
Q3 20248 Jul 2026 - Q2 2024 delivered 3,200 closings, raised guidance, and maintained strong liquidity.TMHC
Q2 20248 Jul 2026 - Q2 2025 revenue rose 2% to $2.03B, net income $194M, and net sales orders declined 12%.TMHC
Q2 20258 Jul 2026 - Shareholders to vote on Berkshire Hathaway's $72.50 per share all-cash acquisition, with board support.TMHC
Proxy filing12 Jun 2026 - Taylor Morrison to be acquired by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing12 Jun 2026 - Definitive acquisition agreement reached; shareholders to vote, with no immediate business changes.TMHC
Proxy filing5 Jun 2026 - Definitive agreement for acquisition by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing5 Jun 2026